Samira Massachi

✔ Strategic Market Access Initiatives – Lead and execute market access strategies to maximize reimbursement potential and optimize pricing for small to midsize pharmaceutical and medical device companies, leveraging AI-driven insights for data-driven decision-making.

✔ Global Health Technology Assessment (HTA) Submissions – Drive early scientific advice and submissions to HTA bodies, including NICE, G-BA, and HAS, ensuring alignment with evolving regulatory and payer landscapes.

✔ Innovative Payer Engagement –Develop cutting-edge payer engagement tools, pricing frameworks, and HEOR analyses to enhance product value, secure reimbursement, and broaden patient access, supported by AI-enabled analytics and modeling.

✔ Evidence Generation & Value Demonstration – Design and implement evidence-generation plans in line with global market access roadmaps, expediting coverage and market entry for novel therapies through AI-enhanced research and forecasting.

✔ AI-Driven Efficiency & Digital Innovation – Stay at the forefront of emerging AI tools and digital platforms, continuously improving internal processes and creating scalable solutions that boost productivity, optimize resource allocation, and enhance client outcomes.

✔ Business Growth & Client Expansion – Champion new business initiatives, cultivating long-term partnerships with biopharma clients, expanding service offerings, and driving revenue growth by over 1 million dollars through innovative, tech-enabled strategies.

✔ Cross-Functional Leadership & Talent Development – Manage, mentor, and empower high-performing teams, fostering data-driven decision-making and accelerating product uptake in competitive markets, while championing adoption of AI platforms to drive efficiency.

✔ Pricing & Reimbursement Excellence – Directed complex pricing and reimbursement strategy projects across multiple therapeutic areas, ensuring seamless payer alignment and optimal market access for clients.

✔ Global Market Access Leadership – Designed and executed comprehensive global market access roadmaps for new product launches, mitigating payer barriers and securing broad reimbursement approvals.

✔ Stakeholder & Payer Engagement – Led high-level advisory boards and strategic stakeholder engagements, refining payer value propositions and fostering alignment with key decision-makers.

✔ Business Development & Growth – Identified and capitalized on new client engagement opportunities, driving strategic business growth and expanding service offerings.

✔ Leadership & Talent Development – Mentored and developed high-potential junior team members, enhancing their strategic acumen, analytical expertise, and client communication skills.

✔ Health Economic Modeling – Conducted comprehensive health economic modeling and evidence synthesis to support successful reimbursement submissions and payer negotiations.

✔ Payer Communication Strategy – Collaborated with clients on payer strategy, providing strategic insights and competitive landscape assessments to inform value communication efforts.

✔ Market Positioning – Delivered strategic insights to optimize pricing and market positioning for pipeline assets, achieving favorable reimbursement outcomes.

✔ Payer Engagement Training – Developed tailored training materials for payers and Medical Outcomes Science Liaisons (MOSLs) to enhance engagement and educational outreach.

✔ Value Dossiers & Publications – Assisted in the development of value dossiers, real-world evidence (RWE) studies, and HEOR publications to support market access strategies for innovative therapies.

✔ Payer Research & Competitive Intelligence – Conducted in-depth payer research and competitive intelligence analyses to inform strategic recommendations and enhance product adoption in key markets.

✔ Interactive Payer Tools – Contributed to the design and implementation of interactive payer value tools and decision-making frameworks, empowering clients to engage effectively with payers.

• Initiated process improvements based on thorough analysis of internal operations data resulting in enhanced productivity levels.

✔ Value Propositions & Dossiers – Developed compelling value propositions, AMCP dossiers, and GVD dossiers to advance market access strategies for pharmaceutical products.

✔ Data Synthesis & Communication – Synthesized complex clinical and economic data into clear, actionable insights for payers, providers, and healthcare professionals.

✔ Collaborative Messaging Alignment – Partnered with HEOR and medical affairs teams to ensure messaging aligned with scientific evidence and reflected market dynamics.

✔ Pharmacovigilance & Drug Safety – Gained hands-on experience in adverse event reporting and literature surveillance, supporting drug safety and medical information teams.
✔ Compendia Surveillance – Conducted compendia research (Micromedex, Facts & Comparisons, DrugDex) to track updates on Amgen and competitor products.
✔ Health Economics & Cost-Effectiveness – Developed a business plan for Medscape technology, assessing cost-effectiveness for Amgen’s product portfolio.
✔ Regulatory & Legal Research – Researched Amicus Curiae and off-label promotion legal cases, delivering key insights via a PowerPoint presentation to Amgen’s senior leadership.
✔ HEOR & Market Access Analysis – Created and presented a cost-effectiveness analysis of rheumatoid arthritis treatments, aligning with health economics and outcomes research (HEOR) principles.
✔ Scientific & Medical Engagement – Participated in weekly journal clubs and therapeutic area meetings (inflammatory, oncology, and metabolic bone), delivering case reports and regulatory updates to internal teams.
✔ Cross-Functional Collaboration – Engaged with key Amgen departments, including medical information, regulatory science, health economics, medical affairs, and clinical trials, ensuring strategic alignment across functions.